Titan Hikes on Closing IPO
Titan Cement International SA (NYSE:TTAM) reported that its Titan America subsidiary and parent company of its U.S. operations, today closed its initial public offering of 24,000,000 common shares at a price to the public of $16.00 per share. The IPO consists of 9,000,000 new common shares issued and sold by Titan America and 15,000,000 existing common shares sold by Titan Cement International SA. Titan America’s common shares began trading on the New York Stock Exchange under the ticker symbol “TTAM” on February 7. Titan America received net proceeds of approximately $136,800,000 million, after deducting underwriting discounts and commissions, which will be used for capital expenditures and other general corporate purposes, including to fund investments in technologies and Titan America’s growth strategies and to pursue strategic acquisitions that complement Titan America’s business.Titan Cement International SA received net proceeds of approximately $228,000,000, after deducting underwriting discounts and commissions.As of the closing of the IPO, Titan Cement International SA owns 160,362,465 common shares of Titan America, representing 87% of the total outstanding common shares.TTAM shares gained 31 cents, or 2.1%, to $17.01.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


